Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001387131-22-010981
Filing Date
2022-10-31
Accepted
2022-10-31 16:08:09
Documents
1
Group Members
MAMOURA DIVERSIFIED GLOBAL HOLDINGS PJSCMDC CAPITAL PARTNERS (VENTURES) GP, LPMDC CAPITAL PARTNERS (VENTURES), LPMIC CAPITAL MANAGEMENT UK LLPMIC CAPITAL PARTNERS (PUBLIC) PARALLEL CAYMAN, LP

Document Format Files

Seq Description Document Type Size
1 AMENDED FORM SC 13D rxrx-sc13da_102722.htm SC 13D/A 176417
  Complete submission text file 0001387131-22-010981.txt   178269
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Subject) CIK: 0001601830 (see all company filings)

EIN.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92498 | Film No.: 221346049
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address P.O. BOX 45005 ABU DHABI C0 00000
Business Address P.O. BOX 45005 ABU DHABI C0 00000 971-2413-0000
Mubadala Investment Co PJSC (Filed by) CIK: 0001704268 (see all company filings)

EIN.: 000000000 | State of Incorp.: C0 | Fiscal Year End: 1231
Type: SC 13D/A